| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |